Bruker Corp (BRKR)
53.24
-1.25
(-2.29%)
USD |
NASDAQ |
Nov 15, 09:50
Bruker Cash from Operations (Quarterly): 38.40M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 38.40M |
| June 30, 2024 | 1.10M |
| March 31, 2024 | 21.80M |
| December 31, 2023 | 205.50M |
| September 30, 2023 | 44.10M |
| June 30, 2023 | 13.00M |
| March 31, 2023 | 87.50M |
| December 31, 2022 | 171.50M |
| September 30, 2022 | 69.50M |
| June 30, 2022 | -44.40M |
| March 31, 2022 | 77.80M |
| December 31, 2021 | 138.60M |
| September 30, 2021 | 23.90M |
| June 30, 2021 | 21.90M |
| March 31, 2021 | 98.00M |
| December 31, 2020 | 203.00M |
| September 30, 2020 | 82.40M |
| June 30, 2020 | 11.80M |
| March 31, 2020 | 35.00M |
| December 31, 2019 | 136.20M |
| September 30, 2019 | 52.40M |
| June 30, 2019 | 10.60M |
| March 31, 2019 | 14.20M |
| December 31, 2018 | 132.30M |
| September 30, 2018 | 27.50M |
| Date | Value |
|---|---|
| June 30, 2018 | 36.10M |
| March 31, 2018 | 43.80M |
| December 31, 2017 | 103.70M |
| September 30, 2017 | 35.30M |
| June 30, 2017 | -17.20M |
| March 31, 2017 | 32.60M |
| December 31, 2016 | 90.80M |
| September 30, 2016 | 35.90M |
| June 30, 2016 | 18.10M |
| March 31, 2016 | -14.00M |
| December 31, 2015 | 149.60M |
| September 30, 2015 | 54.10M |
| June 30, 2015 | -1.50M |
| March 31, 2015 | 27.00M |
| December 31, 2014 | 69.30M |
| September 30, 2014 | 13.50M |
| June 30, 2014 | 13.00M |
| March 31, 2014 | 18.50M |
| December 31, 2013 | 131.40M |
| September 30, 2013 | 38.50M |
| June 30, 2013 | -6.70M |
| March 31, 2013 | -18.20M |
| December 31, 2012 | 90.90M |
| September 30, 2012 | 0.30M |
| June 30, 2012 | 37.10M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-44.40M
Minimum
Jun 2022
205.50M
Maximum
Dec 2023
71.83M
Average
56.80M
Median
Cash from Operations (Quarterly) Benchmarks
| Azenta Inc | 1.791M |
| Harvard Bioscience Inc | -0.842M |
| Bionano Genomics Inc | -20.98M |
| Akoya Biosciences Inc | -11.04M |
| Singular Genomics Systems Inc | -18.04M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -67.60M |
| Cash from Financing (Quarterly) | -2.70M |
| Free Cash Flow | 156.70M |
| Free Cash Flow Per Share (Quarterly) | 0.0382 |
| Free Cash Flow to Equity (Quarterly) | -133.10M |
| Free Cash Flow to Firm (Quarterly) | 12.61M |
| Free Cash Flow Yield | 1.99% |